The RAGE Gly82Ser polymorphism is not associated with cardiovascular disease in the Framingham offspring study (original) (raw)

The −374A allele of the receptor for advanced glycation end products (RAGE) gene promoter is a protective factor against cardiovascular lesions in type 2 diabetes mellitus patients

Emanuel de Souza

Clinical Chemical Laboratory Medicine, 2007

View PDFchevron_right

374T/A polymorphism of the RAGE gene promoter in relation to severity of coronary atherosclerosis

Clinica Chimica Acta, 2005

View PDFchevron_right

Association of Polymorphism in the Receptor for Advanced Glycation End Products (RAGE) Gene with Circulating RAGE Levels

The Journal of Clinical Endocrinology & Metabolism, 2009

View PDFchevron_right

Association analysis of− 429T/C and− 374T/A polymorphisms of receptor of advanced glycation end products (RAGE) gene in Malaysian with type 2 diabetic …

Diabetes Research and …, 2011

View PDFchevron_right

Identification of polymorphisms in the receptor for advanced glycation end products (RAGE) gene: prevalence in type 2 diabetes and ethnic groups

Diabetes, 1998

View PDFchevron_right

Gly82Ser Polymorphism of the Receptor for Advanced Glycation End Products Gene (RAGE) and the Endogenous Secretory RAGE (esRAGE) and its Association with Diabetic Retinopathy in Type 2 Diabetic Patients

Bulletin of Egyptian Society for Physiological Sciences

View PDFchevron_right

Genetic variants in the receptor for advanced glycation end products (RAGE) gene were associated with circulating soluble RAGE level but not with renal function among Asians with type 2 diabetes: a genome-wide association study

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2016

View PDFchevron_right

Receptor for advanced glycation end-product (RAGE) gene polymorphism 2245G/A is associated with pro-inflammatory, oxidative-glycation markers and sRAGE in diabetic retinopathy

Gene, 2013

View PDFchevron_right

The −374T/A RAGE Polymorphism Protects Against Future Cardiac Events in Nondiabetic Patients with Coronary Artery Disease

Colomba Falcone

Archives of Medical Research, 2008

View PDFchevron_right

Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes

Ageing Research Reviews, 2002

View PDFchevron_right

Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetes

Diabetologia, 2011

View PDFchevron_right

RAGE: a novel biological and genetic marker for vascular disease

Anastasia Z Kalea

Clinical science (London, England : 1979), 2009

View PDFchevron_right

The Functional -374 T/A RAGE Gene Polymorphism Is Associated With Proteinuria and Cardiovascular Disease in Type 1 Diabetic Patients

C. Forsblom, Per-henrik Groop

Diabetes, 2003

View PDFchevron_right

The −374A allele of the receptor for advanced glycation end products gene is associated with a decreased risk of ischemic heart disease in African-Brazilians with type 2 diabetes

Molecular Genetics and Metabolism, 2005

View PDFchevron_right

Receptor for advanced glycation end products gene polymorphisms in cardiac syndrome X

Biomedical Reports

View PDFchevron_right

Glycation and diabetes: The RAGE connection

2002

View PDFchevron_right

Association of the receptor for advanced glycation end-products (RAGE) gene polymorphisms in Malaysian patients with chronic kidney disease

Umah Rani Kuppusamy

PeerJ, 2016

View PDFchevron_right

Association of RAGE gene polymorphism with circulating AGEs level and paraoxonase activity in relation to macro-vascular complications in Indian type 2 diabetes mellitus patients

Gene, 2013

View PDFchevron_right

Plasma Levels of Soluble Receptor for Advanced Glycation End Products and Coronary Artery Disease in Nondiabetic Men

Colomba Falcone

Arteriosclerosis, Thrombosis, and Vascular Biology, 2005

View PDFchevron_right

Association of RAGE gene polymorphism with vascular complications in Indian type 2 diabetes mellitus patients

Diabetes Research and Clinical Practice, 2014

View PDFchevron_right

The effects of Advanced Glycation End Products (RAGE)-374T/A and Gly82Ser variants and soluble-RAGE levels to obesity in children

Cellular and molecular biology, 2016

View PDFchevron_right

RAGE polymorphisms and the heritability of insulin resistance: the Leeds family study

Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease, 2005

View PDFchevron_right

Plasma Levels of Soluble Receptor for Advanced Glycation End Products and Coronary Atherosclerosis: Possible Correlation with Clinical Presentation

Benedetta Matrone

Disease Markers, 2013

View PDFchevron_right

Pathological Implications of Receptor for Advanced Glycation End-Product (AGER) Gene Polymorphism

Isabelle Creveaux

Disease Markers, 2019

View PDFchevron_right

Pathological Implications of Receptor for Advanced Glycation End-Product (AGER) Gene Polymorphism

Isabelle Creveaux

Disease Markers

View PDFchevron_right

JPMA-2020-01-184 Association analysis of -429T/C receptor for advanced glycation end products (RAGE) gene polymorphism with type 2 diabetic retinopathy and serum soluble RAGE levels in Pakistani patients

Journal of the Pakistan Medical Association, 2020

View PDFchevron_right

Gene polymorphisms (G82S, 1704G/T, 2184A/G and 2245G/A) of the receptor of advanced glycation end products (RAGE) in plaque psoriasis

L. Izakovičová-hollá

Archives of Dermatological Research, 2002

View PDFchevron_right